pmc-enju-pas Home  

PMC:1310901 / 19754-20782 JSONTXT 15 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T9706 0-2 FW denotes In
T9707 3-8 FW denotes vitro
T9708 9-20 NN denotes methylation
T9709 21-23 IN denotes of
T9710 24-26 DT denotes an
T9711 27-32 NN denotes IRF-4
T9712 33-50 JJ denotes promoter-reporter
T9713 51-60 NN denotes construct
T9714 61-70 VB denotes decreases
T9715 71-74 PRP-DOLLAR- denotes its
T9716 75-83 NN denotes activity
T9717 84-86 TO denotes To
T9718 87-94 VB denotes provide
T9719 95-103 NN denotes evidence
T9720 104-107 IN denotes for
T9721 108-109 DT denotes a
T9722 110-116 JJ denotes direct
T9723 117-123 NN denotes effect
T9724 124-126 IN denotes of
T9725 127-140 JJ denotes methylational
T9726 141-147 NN denotes status
T9727 148-150 IN denotes on
T9728 151-156 NN denotes IRF-4
T9729 157-165 NN denotes promoter
T9730 166-174 NN denotes activity
T9731 175-177 PRP denotes we
T9732 178-187 VB denotes performed
T9733 188-196 NN denotes reporter
T9734 197-201 NN denotes gene
T9735 202-208 NN denotes assays
T9736 209-213 IN denotes with
T9737 214-219 NN denotes IRF-4
T9738 220-228 NN denotes promoter
T9739 229-239 NN denotes constructs
T9740 240-246 IN denotes before
T9741 247-250 CC denotes and
T9742 251-256 IN denotes after
T9743 257-262 PRP-DOLLAR- denotes their
T9744 263-265 FW denotes in
T9745 266-271 FW denotes vitro
T9746 272-283 NN denotes methylation
T9747 285-286 DT denotes A
T9748 287-295 JJ denotes complete
T9749 296-307 NN denotes methylation
T9750 308-310 IN denotes of
T9751 311-316 DT denotes these
T9752 317-327 NN denotes constructs
T9753 328-331 VB denotes was
T9754 332-339 VB denotes checked
T9755 340-343 IN denotes via
T9756 344-355 NN denotes restriction
T9757 356-362 NN denotes assays
T9758 363-367 IN denotes with
T9759 368-389 JJ denotes methylation-sensitive
T9760 390-403 NN denotes endonucleases
T9761 404-405 -LRB- denotes (
T9762 405-411 NN denotes Figure
T9763 412-414 NN denotes 5A
T9764 414-415 -RRB- denotes )
T9765 417-429 RB denotes Intriguingly
T9766 429-430 -COMMA- denotes ,
T9767 431-442 NN denotes methylation
T9768 443-445 IN denotes of
T9769 446-449 DT denotes the
T9770 450-455 NN denotes IRF-4
T9771 456-464 NN denotes promoter
T9772 465-478 RB denotes significantly
T9773 479-488 VB denotes decreased
T9774 489-497 NN denotes promoter
T9775 498-506 NN denotes activity
T9776 507-509 IN denotes in
T9777 510-524 JJ denotes IRF-4-positive
T9778 525-529 NN denotes SD-1
T9779 530-535 NN denotes cells
T9780 536-538 IN denotes by
T9781 539-543 CD denotes 85.0
T9782 543-544 NN denotes %
T9783 545-546 -LRB- denotes (
T9784 546-552 NN denotes Figure
T9785 553-555 NN denotes 5B
T9786 555-556 -RRB- denotes )
T9787 558-561 DT denotes The
T9788 562-571 JJ denotes silencing
T9789 572-578 NN denotes effect
T9790 579-581 IN denotes of
T9791 582-585 NN denotes CpG
T9792 586-597 NN denotes methylation
T9793 598-601 VB denotes was
T9794 602-605 RB denotes not
T9795 606-616 JJ denotes restricted
T9796 617-619 TO denotes to
T9797 620-634 JJ denotes IRF-4-positive
T9798 635-640 NN denotes cells
T9799 640-641 -COMMA- denotes ,
T9800 642-647 IN denotes since
T9801 648-650 FW denotes in
T9802 651-656 FW denotes vitro
T9803 657-668 NN denotes methylation
T9804 669-672 VB denotes led
T9805 673-675 TO denotes to
T9806 676-677 DT denotes a
T9807 678-682 CD denotes 92.9
T9808 682-683 NN denotes %
T9809 684-694 NN denotes abrogation
T9810 695-697 IN denotes of
T9811 698-706 NN denotes promoter
T9812 707-715 NN denotes activity
T9813 716-718 IN denotes in
T9814 719-733 JJ denotes IRF-4-negative
T9815 734-740 NN denotes Jurkat
T9816 741-746 NN denotes cells
T9817 747-748 -LRB- denotes (
T9818 748-754 NN denotes Figure
T9819 755-757 NN denotes 5C
T9820 757-758 -RRB- denotes )
T9821 760-762 IN denotes In
T9822 763-771 NN denotes contrast
T9823 771-772 -COMMA- denotes ,
T9824 773-780 NN denotes control
T9825 781-792 NN denotes methylation
T9826 793-795 IN denotes of
T9827 796-797 DT denotes a
T9828 798-806 NN denotes reporter
T9829 807-816 NN denotes construct
T9830 817-821 IN denotes with
T9831 822-823 DT denotes a
T9832 824-833 JJ denotes different
T9833 834-842 NN denotes promoter
T9834 843-844 -LRB- denotes (
T9835 844-848 NN denotes FasL
T9836 848-849 -RRB- denotes )
T9837 850-852 RB denotes as
T9838 853-857 RB denotes well
T9839 858-860 IN denotes as
T9840 861-863 DT denotes an
T9841 864-869 JJ denotes empty
T9842 870-876 NN denotes vector
T9843 877-880 VB denotes had
T9844 881-883 DT denotes no
T9845 884-890 NN denotes effect
T9846 891-893 IN denotes on
T9847 894-897 DT denotes the
T9848 898-906 NN denotes reporter
T9849 907-915 NN denotes activity
T9850 916-917 -LRB- denotes (
T9851 917-921 NN denotes data
T9852 922-925 RB denotes not
T9853 926-931 VB denotes shown
T9854 931-932 -RRB- denotes )
T9855 934-939 DT denotes These
T9856 940-944 NN denotes data
T9857 945-951 VB denotes proved
T9858 952-953 DT denotes a
T9859 954-960 JJ denotes direct
T9860 961-972 NN denotes association
T9861 973-980 IN denotes between
T9862 981-992 NN denotes methylation
T9863 993-996 CC denotes and
T9864 997-1005 NN denotes activity
T9865 1006-1008 IN denotes of
T9866 1009-1012 DT denotes the
T9867 1013-1018 NN denotes IRF-4
T9868 1019-1027 NN denotes promoter
R8042 T9707 T9706 arg1Of vitro,In
R8043 T9708 T9707 arg1Of methylation,vitro
R8044 T9708 T9709 arg1Of methylation,of
R8045 T9708 T9714 arg1Of methylation,decreases
R8046 T9713 T9709 arg2Of construct,of
R8047 T9713 T9710 arg1Of construct,an
R8048 T9713 T9711 arg1Of construct,IRF-4
R8049 T9713 T9712 arg1Of construct,promoter-reporter
R8050 T9716 T9714 arg2Of activity,decreases
R8051 T9716 T9715 arg1Of activity,its
R8052 T9718 T9717 arg1Of provide,To
R8053 T9719 T9718 arg2Of evidence,provide
R8054 T9719 T9720 arg1Of evidence,for
R8055 T9723 T9720 arg2Of effect,for
R8056 T9723 T9721 arg1Of effect,a
R8057 T9723 T9722 arg1Of effect,direct
R8058 T9723 T9724 arg1Of effect,of
R8059 T9723 T9727 arg1Of effect,on
R8060 T9726 T9724 arg2Of status,of
R8061 T9726 T9725 arg1Of status,methylational
R8062 T9730 T9727 arg2Of activity,on
R8063 T9730 T9728 arg1Of activity,IRF-4
R8064 T9730 T9729 arg1Of activity,promoter
R8065 T9731 T9718 arg1Of we,provide
R8066 T9731 T9732 arg1Of we,performed
R8067 T9732 T9717 modOf performed,To
R8068 T9732 T9740 arg1Of performed,before
R8069 T9732 T9742 arg1Of performed,after
R8070 T9735 T9732 arg2Of assays,performed
R8071 T9735 T9733 arg1Of assays,reporter
R8072 T9735 T9734 arg1Of assays,gene
R8073 T9735 T9736 arg1Of assays,with
R8074 T9739 T9736 arg2Of constructs,with
R8075 T9739 T9737 arg1Of constructs,IRF-4
R8076 T9739 T9738 arg1Of constructs,promoter
R8077 T9740 T9741 arg1Of before,and
R8078 T9742 T9741 arg2Of after,and
R8079 T9745 T9744 arg1Of vitro,in
R8080 T9746 T9740 arg2Of methylation,before
R8081 T9746 T9742 arg2Of methylation,after
R8082 T9746 T9743 arg1Of methylation,their
R8083 T9746 T9745 arg1Of methylation,vitro
R8084 T9749 T9747 arg1Of methylation,A
R8085 T9749 T9748 arg1Of methylation,complete
R8086 T9749 T9750 arg1Of methylation,of
R8087 T9749 T9753 arg1Of methylation,was
R8088 T9749 T9754 arg2Of methylation,checked
R8089 T9752 T9750 arg2Of constructs,of
R8090 T9752 T9751 arg1Of constructs,these
R8091 T9754 T9753 arg2Of checked,was
R8092 T9754 T9755 arg1Of checked,via
R8093 T9757 T9755 arg2Of assays,via
R8094 T9757 T9756 arg1Of assays,restriction
R8095 T9757 T9758 arg1Of assays,with
R8096 T9760 T9758 arg2Of endonucleases,with
R8097 T9760 T9759 arg1Of endonucleases,methylation-sensitive
R8098 T9760 T9761 arg1Of endonucleases,(
R8099 T9763 T9761 arg2Of 5A,(
R8100 T9763 T9762 arg1Of 5A,Figure
R8101 T9764 T9761 arg3Of ),(
R8102 T9767 T9768 arg1Of methylation,of
R8103 T9767 T9773 arg1Of methylation,decreased
R8104 T9771 T9768 arg2Of promoter,of
R8105 T9771 T9769 arg1Of promoter,the
R8106 T9771 T9770 arg1Of promoter,IRF-4
R8107 T9773 T9765 arg1Of decreased,Intriguingly
R8108 T9773 T9766 arg1Of decreased,","
R8109 T9773 T9772 arg1Of decreased,significantly
R8110 T9773 T9780 arg1Of decreased,by
R8111 T9775 T9773 arg2Of activity,decreased
R8112 T9775 T9774 arg1Of activity,promoter
R8113 T9775 T9776 arg1Of activity,in
R8114 T9779 T9776 arg2Of cells,in
R8115 T9779 T9777 arg1Of cells,IRF-4-positive
R8116 T9779 T9778 arg1Of cells,SD-1
R8117 T9782 T9780 arg2Of %,by
R8118 T9782 T9781 arg1Of %,85.0
R8119 T9782 T9783 arg1Of %,(
R8120 T9785 T9783 arg2Of 5B,(
R8121 T9785 T9784 arg1Of 5B,Figure
R8122 T9786 T9783 arg3Of ),(
R8123 T9789 T9787 arg1Of effect,The
R8124 T9789 T9788 arg1Of effect,silencing
R8125 T9789 T9790 arg1Of effect,of
R8126 T9789 T9793 arg1Of effect,was
R8127 T9789 T9795 arg1Of effect,restricted
R8128 T9792 T9790 arg2Of methylation,of
R8129 T9792 T9791 arg1Of methylation,CpG
R8130 T9793 T9794 arg1Of was,not
R8131 T9793 T9799 arg1Of was,","
R8132 T9793 T9800 arg1Of was,since
R8133 T9795 T9793 arg2Of restricted,was
R8134 T9795 T9796 arg1Of restricted,to
R8135 T9798 T9796 arg2Of cells,to
R8136 T9798 T9797 arg1Of cells,IRF-4-positive
R8137 T9802 T9801 arg1Of vitro,in
R8138 T9803 T9802 arg1Of methylation,vitro
R8139 T9803 T9804 arg1Of methylation,led
R8140 T9804 T9800 arg2Of led,since
R8141 T9804 T9805 arg1Of led,to
R8142 T9807 T9808 arg1Of 92.9,%
R8143 T9809 T9805 arg2Of abrogation,to
R8144 T9809 T9806 arg1Of abrogation,a
R8145 T9809 T9807 arg1Of abrogation,92.9
R8146 T9809 T9810 arg1Of abrogation,of
R8147 T9809 T9813 arg1Of abrogation,in
R8148 T9812 T9810 arg2Of activity,of
R8149 T9812 T9811 arg1Of activity,promoter
R8150 T9816 T9813 arg2Of cells,in
R8151 T9816 T9814 arg1Of cells,IRF-4-negative
R8152 T9816 T9815 arg1Of cells,Jurkat
R8153 T9816 T9817 arg1Of cells,(
R8154 T9819 T9817 arg2Of 5C,(
R8155 T9819 T9818 arg1Of 5C,Figure
R8156 T9820 T9817 arg3Of ),(
R8157 T9822 T9821 arg2Of contrast,In
R8158 T9825 T9824 arg1Of methylation,control
R8159 T9825 T9826 arg1Of methylation,of
R8160 T9825 T9830 arg1Of methylation,with
R8161 T9825 T9843 arg1Of methylation,had
R8162 T9829 T9826 arg2Of construct,of
R8163 T9829 T9827 arg1Of construct,a
R8164 T9829 T9828 arg1Of construct,reporter
R8165 T9833 T9831 arg1Of promoter,a
R8166 T9833 T9832 arg1Of promoter,different
R8167 T9833 T9834 arg1Of promoter,(
R8168 T9833 T9839 arg1Of promoter,as
R8169 T9835 T9834 arg2Of FasL,(
R8170 T9836 T9834 arg3Of ),(
R8171 T9839 T9830 arg2Of as,with
R8172 T9839 T9837 arg1Of as,as
R8173 T9839 T9838 arg1Of as,well
R8174 T9842 T9839 arg2Of vector,as
R8175 T9842 T9840 arg1Of vector,an
R8176 T9842 T9841 arg1Of vector,empty
R8177 T9843 T9821 arg1Of had,In
R8178 T9843 T9823 arg1Of had,","
R8179 T9845 T9843 arg2Of effect,had
R8180 T9845 T9844 arg1Of effect,no
R8181 T9845 T9846 arg1Of effect,on
R8182 T9849 T9846 arg2Of activity,on
R8183 T9849 T9847 arg1Of activity,the
R8184 T9849 T9848 arg1Of activity,reporter
R8185 T9849 T9850 arg1Of activity,(
R8186 T9851 T9850 arg2Of data,(
R8187 T9851 T9853 arg2Of data,shown
R8188 T9853 T9852 arg1Of shown,not
R8189 T9854 T9850 arg3Of ),(
R8190 T9856 T9855 arg1Of data,These
R8191 T9856 T9857 arg1Of data,proved
R8192 T9860 T9857 arg2Of association,proved
R8193 T9860 T9858 arg1Of association,a
R8194 T9860 T9859 arg1Of association,direct
R8195 T9860 T9861 arg1Of association,between
R8196 T9862 T9863 arg1Of methylation,and
R8197 T9863 T9861 arg2Of and,between
R8198 T9863 T9865 arg1Of and,of
R8199 T9864 T9863 arg2Of activity,and
R8200 T9868 T9865 arg2Of promoter,of
R8201 T9868 T9866 arg1Of promoter,the
R8202 T9868 T9867 arg1Of promoter,IRF-4